Assessing the relation between systemic lupus erythematosus and metabolic syndrome in Syria: a cross-sectional study

Table 2 The presence of metabolic syndrome and distribution of SLEDAI among patients

		Number (N)	Per cent (%)
Metabolic Syndrome	No	38	54.3%
Metabolic Syndrome	Yes	32	45.7%
SLEDAI	Remission/mild disease activity	21	30%
	Moderate disease activity	33	47.1%
	Severe disease activity	16	22.9%

ISSN: 2520-1026